Talk:EGFR inhibitors

Needs update since 2010
eg ...Phase 1/2 Study of CK-101 – A Novel Third-Generation EGFR Inhibitor CK-101 (in clinical trials) also targets the T790M mutation - Rod57 (talk) 11:11, 5 October 2016 (UTC)